Larimar Therapeutics Director Thomas Edward Hamilton Buys $187K of Stock
Thomas Edward Hamilton, Director, bought 70,000 shares of Larimar Therapeutics, Inc. at $2.67 a share, worth $187K in total on Nov 12, 2026. Shares held after the trade: 70,000.
Larimar Therapeutics President and CEO Carole Ben-maimon Buys $50K of Stock
Carole Ben-maimon, President and CEO, bought 18,050 shares of Larimar Therapeutics, Inc. at $2.77 a share, worth $50K in total on Nov 11, 2026. Shares held after the trade: 386,326 (+4.9%).
Larimar Therapeutics Director Frank E. Thomas Buys $21.8K of Stock
Frank E. Thomas, Director, bought 8,000 shares of Larimar Therapeutics, Inc. at $2.73 a share, worth $21.8K in total on Nov 11, 2026. Shares held after the trade: 15,000 (+114.3%).
Larimar Therapeutics President and COO John B. Harlow Jr. Buys $49.9K of Stock
John B. Harlow Jr., President and COO, bought 17,800 shares of Larimar Therapeutics, Inc. at $2.80 a share, worth $49.9K in total on Nov 11, 2026. Shares held after the trade: 67,800 (+35.6%).
Larimar Therapeutics CFO Michael Celano Buys $50K of Stock
Michael Celano, CFO, bought 18,460 shares of Larimar Therapeutics, Inc. at $2.71 a share, worth $50K in total on Nov 11, 2026. Shares held after the trade: 234,245 (+8.6%).
Larimar Therapeutics Chief Development Officer Gopi Shankar Buys $13.5K of Stock
Gopi Shankar, Chief Development Officer, bought 5,000 shares of Larimar Therapeutics, Inc. at $2.71 a share, worth $13.5K in total on Nov 11, 2026. Shares held after the trade: 81,443 (+6.5%).